Our top pick for
Sphere 3D Corp is a software-application business based in the US. Sphere 3D shares (ANY) are listed on the NASDAQ and all prices are listed in US Dollars. Sphere 3D employs 32 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$7.90|
|52-week range||$1.23 - $11.98|
|50-day moving average||$6.18|
|200-day moving average||$3.41|
|Wall St. target price||$5.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.83|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||18.09%|
|1 month (2021-09-15)||7.48%|
|3 months (2021-07-15)||216.00%|
|6 months (2021-04-15)||244.98%|
|1 year (2020-10-15)||343.82%|
|2 years (2019-10-15)||517.19%|
|3 years (2018-10-15)||2,368.75%|
|5 years (2016-10-14)||1,362.96%|
|Revenue TTM||$4.8 million|
|Gross profit TTM||$2.2 million|
|Return on assets TTM||-36.15%|
|Return on equity TTM||-122.86%|
|Market capitalisation||$393.4 million|
TTM: trailing 12 months
There are currently 2.1 million Sphere 3D shares held short by investors – that's known as Sphere 3D's "short interest". This figure is 67.2% up from 1.3 million last month.
There are a few different ways that this level of interest in shorting Sphere 3D shares can be evaluated.
Sphere 3D's "short interest ratio" (SIR) is the quantity of Sphere 3D shares currently shorted divided by the average quantity of Sphere 3D shares traded daily (recently around 42.2 million). Sphere 3D's SIR currently stands at 0.05. In other words for every 100,000 Sphere 3D shares traded daily on the market, roughly 50 shares are currently held short.
However Sphere 3D's short interest can also be evaluated against the total number of Sphere 3D shares, or, against the total number of tradable Sphere 3D shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sphere 3D's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Sphere 3D shares in existence, roughly 40 shares are currently held short) or 0.1088% of the tradable shares (for every 100,000 tradable Sphere 3D shares, roughly 109 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Sphere 3D.
Find out more about how you can short Sphere 3D stock.
We're not expecting Sphere 3D to pay a dividend over the next 12 months.
Sphere 3D's shares were split on a 1:8 basis on 5 November 2018. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sphere 3D shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Sphere 3D shares which in turn could have impacted Sphere 3D's share price.
Over the last 12 months, Sphere 3D's shares have ranged in value from as little as $1.23 up to $11.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sphere 3D's is 2.1122. This would suggest that Sphere 3D's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Sphere 3D Corp. provides data management, and desktop and application virtualization solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It enables organizations to deploy a combination of public, private, or hybrid cloud strategies through containerized applications, virtual desktops, virtual storage, and physical hyper-converged platforms. The company offers HVE converged and hyper-converged Infrastructure solutions, such as HVE-STACK high density server solution; HVE-VELOCITY high availability dual enclosure storage area network solution; and HVE 3DGFX, a virtualized desktop infrastructure solution. It also provides G-Series appliance to simplify Windows application migration and to enable access from various devices; and G-Series Cloud solution to provide a virtual appliance to eliminate the task of designing, implementing, and maintaining localized application-hosting environments and related hardware. In addition, the company provides SnapServer network attached storage solutions, including SnapServer XSR40, a 1U server that can be configured with up to four SATA III and SSD drives; SnapServer XSR120, a 2U server, which can be configured with up to 12 SATA III, SAS, and SSD drives; GuardianOS, a storage software solution; and Snap Enterprise Data Replicator that provides multi-directional WAN-optimized replication. Sphere 3D Corp.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.